OPK OPKO Health Inc.

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, being held January 13-16, 2025 at Westin St. Francis hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 15th at 3:00 p.m. Pacific time.

The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website .

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit .

Contacts:

Alliance Advisors IR

Yvonne Briggs, 310-691-7100



or

Bruce Voss, 310-691-7100



EN
09/01/2025

Underlying

OPKOPKO Health Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OPKO Health Inc.

 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Confe...

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference MIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, being held January 13-16, 2025 at Westin St. Francis hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 15th at 3:00 p.m. Pacific time. The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website . About...

16h / 28m 1 EN
 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine ...

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with several types of cancer and multiple sclerosisThere are no current treatments or vaccines for EBVFirst participant dosed with novel investigational EBV vaccine targeting multiple viral proteins in Phase I study WESTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), announces dosing of the first participant in ...

January 7, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
PLAY Dave & Buster's...
PBF PBF Energy Inc... ... (+14)

InsiderInsights.com Daily Ratings Report: December 13, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
PBF PBF ENERGY INC. CLASS A
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
LPSN LIVEPERSON INC.
NSC NORFOLK SOUTHERN CORPORATION
UONEK URBAN ONE INC CLASS D
GNSS GENASYS INC
AGL AGILON HEALTH
MAIA INC.
SES MAIA BIOTECHNOLOGY INC
TKO SES AI CORPORATION
TKO GROUP HOLDINGS
INC.
12/14/24 December 14, 2024 1 EN
Free Trial
OPK OPKO Health In...

Opko Health Inc: 1 director

A director at Opko Health Inc bought 500,000 shares at 1.562USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

OPK OPKO HEALTH INC.
12/12/24 December 12, 2024 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
ITW Illinois Tool W...
OPK OPKO Health In... ... (+8)

InsiderInsights.com Daily Ratings Report: December 11, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ITW ILLINOIS TOOL WORKS INC.
OPK OPKO HEALTH INC.
GLP GLOBAL PARTNERS LP
AUID IPSIDY INC.
TCBX THIRD COAST BANCSHARES INC
UAMY U S ANTIMONY CORP
SRFM SURF AIR MOBILITY INC.
SES SES AI CORPORATION
12/12/24 December 12, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch